Patient Information Leaflet:
Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol
Oral Solution EFG
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly.
Contents of the Leaflet
Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol is indicated for the symptomatic relief of catarrhal and flu processes.
This medication contains three active ingredients.
You should consult a doctor if your condition worsens or does not improve after 3 days. You should only use Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol if you have mild or moderate pain, fever, nasal congestion, and phlegm.
Do not takeParacetamol/Guaifenesina/Fenilefrina Hydrochloride Winadolif:
Warnings and precautions
Important: Contains paracetamol. Do not take it with other medications that contain paracetamol. In case of overdose, consult your doctor immediately, even if you feel well, due to the risk of late severe liver damage. Do not take this medication with any other medications for flu, cold, nasal congestion, or cough suppression.
Be especially careful withParacetamol/Guaifenesina/Fenilefrina Hydrochloride Winadolif:
Consult your doctor or pharmacist before starting to take Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol.
During treatment with Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol, inform your doctor immediately if:
If you have severe diseases, such as severe renal insufficiency or sepsis (when bacteria and their toxins circulate in the blood, causing organ damage), or if you suffer from malnutrition, chronic alcoholism, or if you are also taking flucloxacillin (an antibiotic). A severe disease called metabolic acidosis (an anomaly in the blood and fluids) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe breathing difficulties with deep and rapid breathing, drowsiness, feeling unwell (nausea) and vomiting.
Children
Do not administer Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol to children under 12 years of age.
Other medications andParacetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol
Inform your doctor if you are taking, have recently taken, or may need to take any other medication, particularly:
Use ofParacetamol/Guaifenesina/Fenilefrina Hydrochloride Winadolwith food, beverages, and alcohol
Do not drink alcoholic beverages while using Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol.
Pregnancy and breastfeeding
It is not recommended to take Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol during pregnancy and breastfeeding.
IMPORTANT FOR WOMEN:
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
In case of necessity, Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol can be used during pregnancy. You should use the lowest possible dose that reduces pain or fever and use it for the shortest possible time. Contact your doctor if the pain or fever does not decrease or if you need to take the medication more frequently.
Driving and using machines
This product may cause dizziness or confusion. Do not drive or operate heavy machinery
Paracetamol/Guaifenesina/Fenilefrina Hydrochloride Winadolcontains ethanol, sorbitol, and sunset yellow (E-110):
This medication contains 19% ethanol (alcohol), which corresponds to an amount of 3.062 g per dose, equivalent to 76 ml of beer or 32 ml of wine. This medication is harmful to people with alcoholism. The alcohol content should be taken into account in the case of pregnant or breastfeeding women, children, and high-risk groups, such as patients with liver disease or epilepsy. The amount of alcohol in this medication may alter the effects of other medications. The amount of alcohol in this medication may decrease the ability to drive or operate machinery.
This medication contains 6.7 g of sorbitol in each 20 ml sachet.
Sorbitol is a source of fructose. If your doctor has indicated that you (or your child) have an intolerance to certain sugars, or you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease, in which the patient cannot break down fructose, consult your doctor before taking this medication.
Sorbitol may cause gastrointestinal upset and a mild laxative effect.
This medication may cause allergic reactions because it contains sunset yellow (E-110). It may cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow the administration instructions for this medication indicated by your doctor or pharmacist exactly. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is:
Adults, elderly patients, and children over 12 years: Fill the measuring cup to the 20 ml mark. Take a 20 ml dose every 4 hours as needed.
Use in children:
Do not administer to children under 12 years of age.
If you take moreParacetamol/Guaifenesina/Fenilefrina Hydrochloride Winadolthan you should
If you take too much of this medication, talk to a doctor immediately, even if you feel well. Since too much paracetamol can cause severe liver damage over time. If symptoms persist, consult your doctor.
In case of overdose or accidental ingestion, go to a medical center immediately, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
Like all medications, this medication can cause side effects, although not everyone experiences them. If you experience any of the following serious side effects, stop taking the medication immediately and seek urgent medical attention.
(Rare: affects less than 1 in 1,000 people, but more than 1 in 10,000. Very rare: affects less than 1 in 10,000 people).
Other side effects:
Frequent (may affect up to 1 in 10 people): Loss of appetite, nausea, or vomiting.
Rare (may affect up to 1 in 1,000 people): Mild allergic reactions (such as skin rashes or hives), stomach pain, diarrhea, headache, dizziness, rapid heartbeat (palpitations), high blood pressure, difficulty sleeping (insomnia), nervousness, tremors (shaking), irritability, restlessness, confusion, or anxiety.
Frequency not known (cannot be estimated from available data): A serious disease that can make the blood more acidic (called metabolic acidosis) in patients with severe disease using paracetamol (see section 2).
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C. Validity period once opened: 6 months
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition ofParacetamol/Guaifenesina/Fenilefrina Hydrochloride Winadol
Appearance of the product and package contents
Orange-yellow solution, free of foreign substances and with a characteristic fruit flavor.
160 ml and 240 ml packaging: Amber glass bottle with a child-resistant safety cap made of polypropylene (PP) and low-density polyethylene (LDPE). It contains a graduated dosing cup (20 ml) made of polypropylene (PP) for the correct administration of the medication.
Marketing authorization holder and manufacturer
Marketing authorization holder
Nutra Essential OTC, S.L.
C/ La Granja, 1. 3ª Planta.
Spain
Manufacturer
Farmalider S.A.
C/ Aragoneses 2
28108 Alcobendas, Madrid
Spain
or
Edefarm, S.L.
Polígono Industrial Enchilagar del Rullo, 117,
46191 Villamarchante, Valencia
Spain
Date of the last revision of this leaflet:February 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/